416 related articles for article (PubMed ID: 20960373)
1. Hepatitis A and hepatitis C viruses: divergent infection outcomes marked by similarities in induction and evasion of interferon responses.
Qu L; Lemon SM
Semin Liver Dis; 2010 Nov; 30(4):319-32. PubMed ID: 20960373
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A.
Vazquez C; Tan CY; Horner SM
J Virol; 2019 Dec; 93(23):. PubMed ID: 31534039
[TBL] [Abstract][Full Text] [Related]
3. Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation.
Colasanti O; Burm R; Huang HE; Riedl T; Traut J; Gillich N; Li TF; Corneillie L; Faure-Dupuy S; Grünvogel O; Heide D; Lee JY; Tran CS; Merle U; Chironna M; Vondran FFW; Esser-Nobis K; Binder M; Bartenschlager R; Heikenwälder M; Meuleman P; Lohmann V
J Hepatol; 2023 Sep; 79(3):645-656. PubMed ID: 37121436
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
[TBL] [Abstract][Full Text] [Related]
5. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
6. EFTUD2 Is a Novel Innate Immune Regulator Restricting Hepatitis C Virus Infection through the RIG-I/MDA5 Pathway.
Zhu C; Xiao F; Hong J; Wang K; Liu X; Cai D; Fusco DN; Zhao L; Jeong SW; Brisac C; Chusri P; Schaefer EA; Zhao H; Peng LF; Lin W; Chung RT
J Virol; 2015 Jul; 89(13):6608-18. PubMed ID: 25878102
[TBL] [Abstract][Full Text] [Related]
7. Innate and adaptive immune responses in HCV infections.
Heim MH; Thimme R
J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
[TBL] [Abstract][Full Text] [Related]
8. MDA5 plays a critical role in interferon response during hepatitis C virus infection.
Cao X; Ding Q; Lu J; Tao W; Huang B; Zhao Y; Niu J; Liu YJ; Zhong J
J Hepatol; 2015 Apr; 62(4):771-8. PubMed ID: 25463548
[TBL] [Abstract][Full Text] [Related]
9. Independent, parallel pathways to CXCL10 induction in HCV-infected hepatocytes.
Brownell J; Wagoner J; Lovelace ES; Thirstrup D; Mohar I; Smith W; Giugliano S; Li K; Crispe IN; Rosen HR; Polyak SJ
J Hepatol; 2013 Oct; 59(4):701-8. PubMed ID: 23770038
[TBL] [Abstract][Full Text] [Related]
10. HepG2 cells mount an effective antiviral interferon-lambda based innate immune response to hepatitis C virus infection.
Israelow B; Narbus CM; Sourisseau M; Evans MJ
Hepatology; 2014 Oct; 60(4):1170-9. PubMed ID: 24833036
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.
Fensterl V; Grotheer D; Berk I; Schlemminger S; Vallbracht A; Dotzauer A
J Virol; 2005 Sep; 79(17):10968-77. PubMed ID: 16103148
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
[TBL] [Abstract][Full Text] [Related]
13. Multi-step regulation of interferon induction by hepatitis C virus.
Oshiumi H; Funami K; Aly HH; Matsumoto M; Seya T
Arch Immunol Ther Exp (Warsz); 2013 Apr; 61(2):127-38. PubMed ID: 23292079
[TBL] [Abstract][Full Text] [Related]
14. Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD.
Qu L; Feng Z; Yamane D; Liang Y; Lanford RE; Li K; Lemon SM
PLoS Pathog; 2011 Sep; 7(9):e1002169. PubMed ID: 21931545
[TBL] [Abstract][Full Text] [Related]
15. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.
Wang Y; Ye L; Wang X; Li J; Song L; Ho W
Innate Immun; 2013; 19(2):193-202. PubMed ID: 23060457
[TBL] [Abstract][Full Text] [Related]
18. NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.
Qin Y; Xue B; Liu C; Wang X; Tian R; Xie Q; Guo M; Li G; Yang D; Zhu H
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956771
[TBL] [Abstract][Full Text] [Related]
19. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
20. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor.
Yang Y; Liang Y; Qu L; Chen Z; Yi M; Li K; Lemon SM
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7253-8. PubMed ID: 17438296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
